PHARMACORP RX INC (PCRX.CA) Stock Income Statement
TSX-V:PCRX - TSX Venture Exchange - CA71714X1050 - Common Stock - Currency: CAD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.80M | 5.79M | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | 25.80K | 38.10K | N/A | N/A | N/A | |||
| Cost Of Goods | 5.99M | 3.61M | N/A | N/A | N/A | |||
| Gross Profit | 3.81M | 2.18M | N/A | N/A | N/A | |||
| Operating Expenses | 5.17M | 3.77M | 578.00K | 563.20K | 26.50K | |||
| Selling, General, and Administrative Expenses | 4.69M | 3.48M | 578.00K | 563.20K | 26.50K | |||
| Operating Income | -1.36M | -1.59M | -578.00K | -563.20K | -26.50K | |||
| Interest Income/Expense | 439.40K | 348.80K | 107.50K | 46.10K | 700.00 | |||
| Other Income/Expense | 125.30K | 82.10K | N/A | N/A | N/A | |||
| Income Before Taxes | -795.40K | -1.16M | -470.40K | -517.10K | -25.80K | |||
| Income Tax | 1.20K | -106.50K | N/A | N/A | N/A | |||
| Net Income | -771.00K | -1.01M | -470.40K | -517.10K | -25.80K | |||
| EBITDA | -882.70K | -1.30M | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.00 | |||
| Statistics | ||||||||
| Gross Profit Margin | 38.85% | 37.70% | N/A | N/A | N/A | |||
| Profit Margin | -7.87% | -17.48% | N/A | N/A | N/A | |||
| Operating Profit Margin | -13.88% | -27.41% | N/A | N/A | N/A | |||
All data in CAD